These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28814738)

  • 61. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
    Kang ZS; Wang C; Han XL; Du JJ; Li YY; Zhang C
    Eur J Med Chem; 2018 Feb; 146():541-553. PubMed ID: 29407979
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction.
    Panda DK; Miao D; Tremblay ML; Sirois J; Farookhi R; Hendy GN; Goltzman D
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7498-503. PubMed ID: 11416220
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals.
    Murayama A; Takeyama K; Kitanaka S; Kodera Y; Kawaguchi Y; Hosoya T; Kato S
    Endocrinology; 1999 May; 140(5):2224-31. PubMed ID: 10218975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of alkyl side chains and terminal hydrophilicity on vitamin D receptor (VDR) agonistic activity based on the diphenylpentane skeleton.
    Misawa T; Yorioka M; Demizu Y; Noguchi-Yachide T; Ohoka N; Kurashima-Kinoshita M; Motoyoshi H; Nojiri H; Kittaka A; Makishima M; Naito M; Kurihara M
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5362-6. PubMed ID: 26432035
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.
    Sochorová K; Budinský V; Rozková D; Tobiasová Z; Dusilová-Sulková S; Spísek R; Bartůnková J
    Clin Immunol; 2009 Oct; 133(1):69-77. PubMed ID: 19660988
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Creation of Potent Vitamin D Receptor Agonists and Antagonists with 2α-(ω-Hydroxyalkylation) Concept to the seco-Steroid Skeleton.
    Kittaka A
    Chimia (Aarau); 2018 Dec; 72(12):859-865. PubMed ID: 30648951
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lithocholic acid-based design of noncalcemic vitamin D receptor agonists.
    Gaikwad S; González CM; Vilariño D; Lasanta G; Villaverde C; Mouriño A; Verlinden L; Verstuyf A; Peluso-Iltis C; Rochel N; Berkowska K; Marcinkowska E
    Bioorg Chem; 2021 Jun; 111():104878. PubMed ID: 33853023
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Confirmation of high-throughput screening data and novel mechanistic insights into VDR-xenobiotic interactions by orthogonal assays.
    Mahapatra D; Franzosa JA; Roell K; Kuenemann MA; Houck KA; Reif DM; Fourches D; Kullman SW
    Sci Rep; 2018 Jun; 8(1):8883. PubMed ID: 29891985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon.
    Misawa T; Tsuji G; Takahashi T; Ochiai E; Takagi KI; Horie K; Kakuda S; Takimoto-Kamimura M; Kurihara M; Demizu Y
    Bioorg Med Chem; 2018 Dec; 26(23-24):6146-6152. PubMed ID: 30446437
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vitamin D therapy in cardiac hypertrophy and heart failure.
    Wu-Wong JR
    Curr Pharm Des; 2011; 17(18):1794-807. PubMed ID: 21631423
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New vitamin D receptor agonists with decreased metabolic stability.
    Werz O; Wiesinger H; Steinmeyer A; Steinhilber D
    Biochem Pharmacol; 2000 Jun; 59(12):1597-601. PubMed ID: 10799658
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Nonsecosteroidal Vitamin D Receptor Modulator Ameliorates Experimental Autoimmune Encephalomyelitis without Causing Hypercalcemia.
    Na S; Ma Y; Zhao J; Schmidt C; Zeng QQ; Chandrasekhar S; Chin WW; Nagpal S
    Autoimmune Dis; 2011 Jan; 2011():132958. PubMed ID: 21318047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis and evaluation of side-chain hydroxylated derivatives of lithocholic acid as potent agonists of the vitamin D receptor (VDR).
    González CM; Gaikwad S; Lasanta G; Loureiro J; Nilsson N; Peluso-Iltis C; Rochel N; Mouriño A
    Bioorg Chem; 2021 Oct; 115():105202. PubMed ID: 34339974
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Carborane-based design of a potent vitamin D receptor agonist.
    Otero R; Seoane S; Sigüeiro R; Belorusova AY; Maestro MA; Pérez-Fernández R; Rochel N; Mouriño A
    Chem Sci; 2016 Feb; 7(2):1033-1037. PubMed ID: 28808527
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcitriol-Mediated Hypercalcemia, Somatostatin Receptors Expression and 25-Hydroxyvitamin D
    Herrera-Martínez Y; Contreras González MJ; Pedraza-Arévalo S; Guerrero Martínez MDC; Rodrigo Martínez Á; González Menchen A; Blanco Molina MA; Gálvez-Moreno MA; Moreno-Vega AL; Luque RM; Herrera-Martínez AD
    Front Endocrinol (Lausanne); 2021; 12():812385. PubMed ID: 35154010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models.
    Kawar N; Maclaughlan S; Horan TC; Uzun A; Lange TS; Kim KK; Hopson R; Singh AP; Sidhu PS; Glass KA; Shaw S; Padbury JF; Vorsa N; Arnold LA; Moore RG; Brard L; Singh RK
    Genes Cancer; 2013 Nov; 4(11-12):524-34. PubMed ID: 24386512
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation.
    Scolletta S; Colletti M; Di Luigi L; Crescioli C
    Mediators Inflamm; 2013; 2013():876319. PubMed ID: 23690671
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selective knockout of the vitamin d receptor in the heart results in cardiac hypertrophy: is the heart a drugable target for vitamin D receptor agonists?
    Simpson RU
    Circulation; 2011 Oct; 124(17):1808-10. PubMed ID: 22025636
    [No Abstract]   [Full Text] [Related]  

  • 80. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
    Minisola S; Cianferotti L; Biondi P; Cipriani C; Fossi C; Franceschelli F; Giusti F; Leoncini G; Pepe J; Bischoff-Ferrari HA; Brandi ML
    Osteoporos Int; 2017 Nov; 28(11):3239-3249. PubMed ID: 28815282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.